Press Release: SmithRx : SmithRx will be First PBM to Offer YUSIMRY, a Humira Biosimilar, for One-Tenth the List Price of Humira

Teaming up with Mark Cuban Cost Plus Drug Company, SmithRx will start offering members access beginning in July 2023 Teaming up with Mark Cuban Cost Plus Drug Company, SmithRx will start offering members access beginning in July 2023